Molbio Diagnostics Limited (BOM:544866)
India flag India · Delayed Price · Currency is INR
1,312.65
-48.75 (-3.58%)
At close: Sep 16, 2026

Molbio Diagnostics Company Description

Molbio Diagnostics Limited, a point-of-care diagnostics company, provides healthcare technologies to diagnose infectious and non-communicable diseases.

It manufactures and sells chip based diagnostic devices, chips and reagents, X-ray equipment's, and single/dual detectors.

It also offers disposable POCT devices, which includes dengue, malaria, and COVID-19 tests; Tabletop analysers, a portable machine that are used to perform molecular or immunodiagnostic tests to detect infectious diseases, such as tuberculosis, human papillomavrus, STIs, and GI disorders.

In addition, the company offers Truenat, a multi-disease real-time polymerase chain reaction platform that enables treatment decisions for various infectious and non-communicable diseases, such as tuberculosis, human immunodeficiency virus, malaria, viral hepatitis, COVID-19, dengue, chikungunya, influenza, H1N1, HPV/cervical cancer, cholera, leprosy, etc.; and Truenat assays.

The company was incorporated in 2000 and is based in Verna, India.

Molbio Diagnostics Limited
CountryIndia
Founded2000
IndustryIn Vitro and In Vivo Diagnostic Substances
Employees1,225
CEOSriram Natarajan

Contact Details

Address:
Plot No. L-46
Verna, 403722
India
Phone91 83 2672 4888
Websitemolbiodiagnostics.com

Stock Details

Ticker Symbol544866
ExchangeBombay Stock Exchange
Fiscal YearApril - March
Reporting CurrencyINR
SIC Code2835

Key Executives

NamePosition
Sriram NatarajanChief Executive Officer
Manan KhokhaniChief Financial Officer
Sangeetha SriramChief Operating Officer
Indraneil BorkakotyHead of Investor Relations